CMS Paid Medicare Drug Costs for Deceased Patients, Audit Reveals
The issue involves the program that began Jan. 1, 2006 by which Medicare subsidizes the drug benefit under Plan D for Medicare enrollees by making payments each month to the beneficiaries selected drug plan. Payment is made for the month to cover direct, reinsurance, and low income cost-sharing for the beneficiaries who enrolled.
"If CMS receives health status information that would either increase or decrease the previous monthly payments, it makes retroactive adjustments to correct the payment costs, reinsurance amounts and low-income subsidies after the end of each year," the OIG said. The last allowable payment is for the month the enrollee died.
The OIG recommended that CMS not only recoup the $3.6 million, but also recover improper payments in a timely manner and implement system enhancements to prevent and detect future improper payments for deceased enrollees.
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- As Medicare Advantage Cuts Loom, Disagreement Over Program's Stability
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Centralizing the Revenue Cycle Protects the Bottom Line
- CA Fines 8 Hospitals for Medical Errors
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- Doctors Feel Pressure to Accept Risk-based Reimbursement
- Surgical Checklists Unused in 10% of Hospitals, CMS Data Shows
- Employers Weigh Risks, Benefits of Private Exchanges
- A Fresh Look at End-of-Life Care
- 3 Management Lessons from a Supermarket Debacle